Sabine Bruse-Merkelbach

Kerpener Str. 62
Koeln, NW 50924, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 162 publications

Diagnostic performance of the microRNA-371a assay in small testicular masses: a real-world cohort study.

Diagnostic performance of the microRNA-371a assay in small testicular masses: a real-world cohort study.

Journal: BJU international

Published: March 13, 2026

Pitfalls in Detecting MET Exon 14 Skipping Variants by DNA- and RNA-Based Next-Generation Sequencing Technologies in a Large Real-World Cohort and Results of the First Multinational External Quality Assessment Schemes.

Pitfalls in Detecting MET Exon 14 Skipping Variants by DNA- and RNA-Based Next-Generation Sequencing Technologies in a Large Real-World Cohort and Results of the First Multinational External Quality Assessment Schemes.

Journal: The Journal of molecular diagnostics : JMD

Published: February 11, 2026

Pitfalls in Detecting MET Exon 14 Skipping Variants by DNA- and RNA-Based Next-Generation Sequencing Technologies in a Large Real-World Cohort and Results of the First Multinational External Quality Assessment Schemes.

Pitfalls in Detecting MET Exon 14 Skipping Variants by DNA- and RNA-Based Next-Generation Sequencing Technologies in a Large Real-World Cohort and Results of the First Multinational External Quality Assessment Schemes.

Journal: The Journal of molecular diagnostics : JMD

Published: February 11, 2026

CuMo-a program to strengthen molecular diagnostics in pathology

CuMo-a program to strengthen molecular diagnostics in pathology

Journal: Pathologie (Heidelberg, Germany)

Published: January 29, 2026

Molecular and clinical characteristics of patients with non-small cell lung cancer (NSCLC) harboring KRAS Q61 mutations to assess therapeutic responses.

Molecular and clinical characteristics of patients with non-small cell lung cancer (NSCLC) harboring KRAS Q61 mutations to assess therapeutic responses.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 12, 2026

ADC Target Profiling in NSCLC: Generalizable AI Separates TROP-2 and cMET Phenotypes.

ADC Target Profiling in NSCLC: Generalizable AI Separates TROP-2 and cMET Phenotypes.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 25, 2025

Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions - a real-world retrospective analysis.

Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions - a real-world retrospective analysis.

Journal: NPJ precision oncology

Published: September 05, 2025

MET-Driven Resistance to Sotorasib in KRAS G12C-Mutant NSCLC and Response to Combined KRAS and MET Inhibition.

MET-Driven Resistance to Sotorasib in KRAS G12C-Mutant NSCLC and Response to Combined KRAS and MET Inhibition.

Journal: JTO clinical and research reports

Published: July 30, 2025

Molecular and Clinical Characteristics of Patients with Non-Small Cell Lung Cancer Harboring KRAS G12V Mutations.

Molecular and Clinical Characteristics of Patients with Non-Small Cell Lung Cancer Harboring KRAS G12V Mutations.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 17, 2025

AI-powered spatial cell phenomics enhances risk stratification in non-small cell lung cancer.

AI-powered spatial cell phenomics enhances risk stratification in non-small cell lung cancer.

Journal: Nature communications

Published: May 27, 2025

Evaluating docetaxel effectiveness in KRAS G12C-mutated NSCLC: insights from a Real-World cohort.

Evaluating docetaxel effectiveness in KRAS G12C-mutated NSCLC: insights from a Real-World cohort.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: May 22, 2025

NGS coverage accurately predicts MET and HER2 (ERBB2) gene amplifications in a real-world non-small cell lung cancer cohort.

NGS coverage accurately predicts MET and HER2 (ERBB2) gene amplifications in a real-world non-small cell lung cancer cohort.

Journal: Frontiers in oncology

Published: April 26, 2025

Showing 1-12 of 162

Last Updated: 09/26/2026